Analyst consensus rating
Bio-Techne Analyst Consensus Rating
TECH analyst consensus rating, coverage count and price target evidence.
Direct answer
Bio-Techne's consensus rating is Hold.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $69.73.
Forecast evidence checked August 4, 2026.
Verified data
- Current price
- $72.14
- Average price target
- $69.73
- High price target
- $73.00
- Low price target
- $50.00
- Target upside
- -3.3%
- Consensus rating
- Hold
- Analysts
- 11
- Evidence date
- August 4, 2026
- Valid through
- August 11, 2026